{"id":"W2109240520","doi":"10.1200/jco.2009.22.9427","title":"Randomized, Double-Blind Trial of Carboplatin and Paclitaxel With Either Daily Oral Cediranib or Placebo in Advanced Non–Small-Cell Lung Cancer: NCIC Clinical Trials Group BR24 Study","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":244,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; Queen's University","funders":"","keywords":"Medicine; Carboplatin; Paclitaxel; Placebo; Clinical trial; Lung cancer; Randomized controlled trial; Oncology; Internal medicine; Clinical endpoint; Double blind; Cancer; Chemotherapy; Cisplatin; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003347118,0.002561094,0.00753713,0.0007764417,0.0006964835,0.001674336,0.001810084,0.003088229,0.007683284],"category_scores_gemma":[0.003769509,0.001041702,0.00188927,0.0006044207,0.001766833,0.001205521,0.0005251121,0.003555242,0.001885587],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001005738,"about_ca_system_score_gemma":0.002175019,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007066692,"about_ca_topic_score_gemma":0.001465312,"domain_scores_codex":[0.9982796,0.00100833,0.0001253548,0.000296188,0.00013765,0.0001529784],"domain_scores_gemma":[0.9981504,0.0004043166,0.0004582213,0.0001681545,0.0001409275,0.0006779625],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9877247,0.004237488,0.0001845629,0.000322454,0.0004204588,0.00001688786,0.00001541842,0.000130672,0.001165225,0.00004764286,0.0004814558,0.00525305],"study_design_scores_gemma":[0.9848266,0.01431025,0.0002360798,0.00001052328,0.00009776527,0.000009203525,0.00000272697,0.0001029802,0.0001292796,0.00004312793,0.0002268502,0.000004689476],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9464034,0.01335473,0.001933422,0.001612378,0.002041806,0.02587861,0.003049876,0.0006475658,0.005078151],"genre_scores_gemma":[0.9482123,0.004534753,0.004895518,0.002542172,0.001126995,0.03012784,0.00223695,0.00008017076,0.006243271],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007683284,"threshold_uncertainty_score":0.02570313,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2009292261068014,"score_gpt":0.563303123281749,"score_spread":0.3623738971749476,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}